Qiagen Manila

Qiagen Manila company information, Employees & Contact Information

Explore related pages

Related company profiles:

QIAGEN Manila is a biotechnology company which provides services related to Supply Chain Management, Customer Care, Finance & Accounting, Technical Services and other sales support activities to QIAGEN's global operations. We complement QIAGEN’s existing Shared Service Center in Wroclaw, Poland. Supporting QIAGEN businesses specifically in the United States and the APAC region, QIAGEN Manila is expected to play an important role in the global provision of services to the company and its clients. The site is home to over 300++ diverse professionals spanning support functions from Technical Service, Customer Care, Finance, HR, Sales Support, and other fields. About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2017, QIAGEN employed approximately 4,700 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com. https://forms.gle/TV3mEBVmZQe6dzFd6

Company Details

Employees
198
Address
Old Lawton Avenue, Mckinley West,philippines
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Taguig City, NCR
Looking for a particular Qiagen Manila employee's phone or email?

Qiagen Manila Questions

News

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG TradingView

Nov 4 Q3 2025 results release — QIAGEN to issue results Nov 4 (22:05 Frankfurt) and host Nov 5 webcast - Stock Titan

Nov 4 Q3 2025 results release — QIAGEN to issue results Nov 4 (22:05 Frankfurt) and host Nov 5 webcast Stock Titan

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast Business Wire

QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds - Yahoo Finance

QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds Yahoo Finance

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - The AI Journal

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast The AI Journal

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability - Business Wire

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability Business Wire

PTA-AFR: QIAGEN N.V.: Pre-announcement of a financial report according to articles 114 - 117 WpHG - TradingView

PTA-AFR: QIAGEN N.V.: Pre-announcement of a financial report according to articles 114 - 117 WpHG TradingView

QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds - Business Wire

QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds Business Wire

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - Yahoo Finance

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership Yahoo Finance

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR TradingView

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels Business Wire

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships - Business Wire

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships Business Wire

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board - Business Wire

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board Business Wire

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) - Business Wire

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) Business Wire

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software - Business Wire

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software Business Wire

QIAGEN delivers solid Q4 2024 growth ahead of outlook - Business Wire

QIAGEN delivers solid Q4 2024 growth ahead of outlook Business Wire

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - Business Wire

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation Business Wire

QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast - Business Wire

QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast Business Wire

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG TradingView

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - Business Wire

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million Business Wire

160 Tests Per Day: QIAGEN's New QIAstat-Dx Rise System Receives FDA Clearance for Rapid Diagnostics - Stock Titan

160 Tests Per Day: QIAGEN's New QIAstat-Dx Rise System Receives FDA Clearance for Rapid Diagnostics Stock Titan

QIAGEN Launches New Custom Solutions for Enhanced Microbial Analysis - Quiver Quantitative

QIAGEN Launches New Custom Solutions for Enhanced Microbial Analysis Quiver Quantitative

QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology - GlobeNewswire

QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology GlobeNewswire

QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results - GlobeNewswire

QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results GlobeNewswire

QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs - GlobeNewswire

QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs GlobeNewswire

QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance - GlobeNewswire

QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance GlobeNewswire

Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement - Yahoo Finance

Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement Yahoo Finance

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery - GlobeNewswire

QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery GlobeNewswire

QIAGEN expands QIAstat-Dx syndromic testing menu in the - GlobeNewswire

QIAGEN expands QIAstat-Dx syndromic testing menu in the GlobeNewswire

DNA Labs International solves significant cold cases with QIAGEN workflow - Police1

DNA Labs International solves significant cold cases with QIAGEN workflow Police1

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples - FinancialContent

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples FinancialContent

Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10 - Thermo Fisher Scientific

Thermo Fisher Scientific Confirms Offer to Acquire QIAGEN Shares Expires on August 10 Thermo Fisher Scientific

Thermo Fisher Scientific to Acquire QIAGEN N.V. - Thermo Fisher Scientific

Thermo Fisher Scientific to Acquire QIAGEN N.V. Thermo Fisher Scientific

Top Qiagen Manila Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant